S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Abilify Maker Otsuka to Buy Avanir for $3.5 Billion (2014/12/2)|
|Otsuka to Buy Avanir for $3.5 Billion (2014/12/2)|
|Japan's Otsuka to buy drug maker Avanir for $3.5 billion|
|Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion|
|AVNR INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Avanir Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Otsuka Pharmaceutical Co., Ltd. -- AVNR (2014/12/2)|
|AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical|
|AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Otsuka Pharmaceutical Co., Ltd.|
|EQUITY ALERT: The Rosen Law Firm Announces Investigation of Avanir Pharmaceuticals Concerning its Proposed Sale to Otsuka Pharmaceutical – AVNR|
|Drug makers face another $65 billion patent cliff (2014/12/10)|
|Block & Leviton LLP Investigates Avanir Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Otsuka Pharmaceutical Co., Ltd.|
Click above to view more mutual fund data and stats for 4768 - Otsuka Corporation.